Description
(Mutations and fusions testing)
Tissue, NA, Fasting or Non Fasting: As suggested by doctor
Sample Required:
FFPE tissue block OR fresh tissue in DCGL Preservative Solution at 2–8°C; tumour content >10%.
Test Time:
Biopsy-dependent. 8–12 working days.
Test Normal Range:
No fixed normal range.
What is the Test?
An NGS test identifying **FGFR2 and FGFR3 mutations and fusions**, commonly relevant in urothelial, bile duct and endometrial cancers.
Test Procedure:
Tissue is sequenced to detect FGFR pathway alterations.
When to Take the Test:
When FGFR-targeting therapies are being evaluated.
Who Should Take This Test:
Patients with tumours where FGFR mutations/fusions influence management.
Precautions for Exceptional Cases (Pregnancy, etc.):
Notify clinician if pregnant; ensure correct tissue handling.